Zoetis Inc. Class A

186.53-0.0700-0.04%Vol 352.08K1Y Perf 36.21%
Jun 22nd, 2021 12:00 DELAYED
BID186.47 ASK186.50
Open186.53 Previous Close186.60
Pre-Market- After-Market-
 - -%  - -
Target Price
186.75 
Analyst Rating
Moderate Buy 1.93
Potential %
0.12 
Finscreener Ranking
★★+     48.02
Insiders Trans % 3/6/12 mo.
-100/-75/-86 
Value Ranking
★★     47.40
Insiders Value % 3/6/12 mo.
-100/-94/-96 
Growth Ranking
★★★★     61.81
Insiders Shares Cnt. % 3/6/12 mo.
-100/-94/-96 
Income Ranking
★★     38.92
Market Cap88.56B 
Earnings Rating
Neutral
Price Range Ratio 52W %
98.59 
Earnings Date
5th Aug 2021

Today's Price Range

185.88187.00

52W Range

131.28187.32

5 Year PE Ratio Range

27.8078.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.50%
1 Month
6.01%
3 Months
19.90%
6 Months
15.31%
1 Year
36.21%
3 Years
117.43%
5 Years
295.08%
10 Years
-

TickerPriceChg.Chg.%
ZTS186.53-0.0700-0.04
AAPL132.520.22000.17
GOOG2 528.99-0.11000.00
MSFT264.371.74000.66
XOM63.731.14001.82
WFC43.570.29000.67
JNJ163.78-0.0600-0.04
FB335.152.86000.86
GE13.04-0.1500-1.14
JPM150.20-0.2300-0.15
Financial StrengthValueIndustryS&P 500US Markets
2.30
3.30
0.62
1.80
10.30
Leverage Ratio 3.80
ProfitabilityValueIndustryS&P 500US Markets
69.40
34.50
40.80
28.30
25.28
RevenueValueIndustryS&P 500US Markets
7.01B
14.77
6.87
7.30
DividendsValueIndustryS&P 500US Markets
0.54
1.00
21.35
18.82
Payout ratio23.00
Earnings HistoryEstimateReportedSurprise %
Q01 20211.041.2621.15
Q04 20200.860.915.81
Q03 20200.891.1023.60
Q02 20200.660.8934.85
Q01 20200.880.957.95
Q04 20190.880.924.55
Q03 20190.890.945.62
Q02 20190.820.909.76
Earnings Per EndEstimateRevision %Trend
6/2021 QR1.07-1.83Negative
9/2021 QR1.13-4.24Negative
12/2021 FY4.502.04Positive
12/2022 FY5.021.83Positive
Next Report Date5th Aug 2021
Estimated EPS Next Report1.07
Estimates Count7
EPS Growth Next 5 Years %12.90
Volume Overview
Volume352.08K
Shares Outstanding474.77M
Trades Count7.23K
Dollar Volume441.11M
Avg. Volume1.94M
Avg. Weekly Volume1.77M
Avg. Monthly Volume1.73M
Avg. Quarterly Volume1.77M

Zoetis Inc. Class A (NYSE: ZTS) stock closed at 186.6 per share at the end of the most recent trading day (a 0.65% change compared to the prior day closing price) with a volume of 1.98M shares and market capitalization of 88.56B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 11300 people. Zoetis Inc. Class A CEO is Kristin C. Peck.

The one-year performance of Zoetis Inc. Class A stock is 36.21%, while year-to-date (YTD) performance is 12.75%. ZTS stock has a five-year performance of 295.08%. Its 52-week range is between 131.28 and 187.32, which gives ZTS stock a 52-week price range ratio of 98.59%

Zoetis Inc. Class A currently has a PE ratio of 50.00, a price-to-book (PB) ratio of 21.53, a price-to-sale (PS) ratio of 12.63, a price to cashflow ratio of 41.90, a PEG ratio of 2.32, a ROA of 13.62%, a ROC of 18.82% and a ROE of 50.56%. The company’s profit margin is 25.28%, its EBITDA margin is 40.80%, and its revenue ttm is $7.01 Billion , which makes it $14.77 revenue per share.

Of the last four earnings reports from Zoetis Inc. Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.07 for the next earnings report. Zoetis Inc. Class A’s next earnings report date is 05th Aug 2021.

The consensus rating of Wall Street analysts for Zoetis Inc. Class A is Moderate Buy (1.93), with a target price of $186.75, which is +0.12% compared to the current price. The earnings rating for Zoetis Inc. Class A stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Zoetis Inc. Class A has a dividend yield of 0.54% with a dividend per share of $1.00 and a payout ratio of 23.00%.

Zoetis Inc. Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 9.23, ATR14 : 3.20, CCI20 : 111.24, Chaikin Money Flow : 0.07, MACD : 3.91, Money Flow Index : 68.94, ROC : 7.35, RSI : 69.18, STOCH (14,3) : 95.34, STOCH RSI : 0.35, UO : 66.94, Williams %R : -4.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Zoetis Inc. Class A in the last 12-months were: Catherine A. Knupp (Option Excercise at a value of $0), Catherine A. Knupp (Sold 21 283 shares of value $3 516 010 ), Frank A. D'Amelio (Option Excercise at a value of $0), Glenn David (Option Excercise at a value of $1 925 113), Glenn David (Sold 26 285 shares of value $4 439 964 ), Gregory Norden (Option Excercise at a value of $0), Heidi C. Chen (Option Excercise at a value of $1 543 927), Heidi C. Chen (Sold 29 192 shares of value $4 946 073 ), James Michael McFarland (Option Excercise at a value of $0), Juan Ramon Alaix (Option Excercise at a value of $9 746 047), Juan Ramon Alaix (Sold 224 817 shares of value $36 544 534 ), Kristin C. Peck (Option Excercise at a value of $1 142 930), Kristin C. Peck (Sold 51 927 shares of value $8 496 201 ), Linda Rhodes (Option Excercise at a value of $0), Linda Rhodes (Sold 1 087 shares of value $173 007 ), Louise M. Parent (Option Excercise at a value of $0), Michael B. McCallister (Option Excercise at a value of $0), Paul M. Bisaro (Option Excercise at a value of $0), Robert Edward Kelly (Option Excercise at a value of $175 402), Robert Edward Kelly (Sold 8 217 shares of value $1 335 260 ), Robert W Scully (Buy at a value of $1 249 931), Robert W Scully (Option Excercise at a value of $0), Roman Trawicki (Option Excercise at a value of $705 613), Roman Trawicki (Sold 14 481 shares of value $2 240 670 ), Roxanne Lagano (Option Excercise at a value of $1 065 095), Roxanne Lagano (Sold 24 000 shares of value $3 968 160 ), Sanjay Khosla (Option Excercise at a value of $0), William C. Steere (Option Excercise at a value of $0), Willie M. Reed (Option Excercise at a value of $0), Willie M. Reed (Sold 3 770 shares of value $599 694 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (53.33 %)
8 (53.33 %)
7 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (46.67 %)
7 (46.67 %)
7 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.93
Moderate Buy
1.93
Moderate Buy
2.00

Zoetis Inc. Class A

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

CEO: Kristin C. Peck

Telephone: +1 973 822-7000

Address: 10 Sylvan Way, Parsippany 07054, NJ, US

Number of employees: 11 300

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

63%37%

Bearish Bullish

64%36%

Bearish Bullish

63%37%

News

Stocktwits